Medicenna Therapeutics Corp. Equity And Liabilities
Medicenna Therapeutics Corp. (MDNAF) had Equity And Liabilities of CAD 36.45 million as of 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes
ifrs-full:EquityAndLiabilities · last filed 2023-06-27
- 2023-03-31: Equity And Liabilities 36.45M CAD.
- 2022-03-31: Equity And Liabilities 23.46M CAD.
- 2021-03-31: Equity And Liabilities 42.25M CAD.
- 2020-03-31: Equity And Liabilities 38.00M CAD.
| Period end | Equity And Liabilities |
|---|---|
| 2023-03-31 | 36.45M CAD 20-F · filed 2023-06-27 |
| 2022-03-31 | 23.46M CAD 20-F · filed 2023-06-27 |
| 2021-03-31 | 42.25M CAD 20-F · filed 2022-06-22 |
| 2020-03-31 | 38.00M CAD 40-F · filed 2021-05-28 |